Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label adolescent study of halobetasol propionate foam for plaque psoriasis
2018-003845-40Phase 2Completed
- Sponsor
- Mayne Pharma
- Start
- Aug 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of halobetasol in plaque psoriasis, sponsored by Mayne Pharma. Primary endpoint: HPA Axis Response to Cosyntropin. Started Aug 2019; status: completed.
02
Drugs
halobetasol
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2018-003845-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003845-40.